Test Strip Market Size (2024 - 2029)

The test strip market is projected to experience significant growth over the forecast period, driven by factors such as the increasing prevalence of diabetes and urinary tract infections, a rising preference for point-of-care testing, and technological advancements in test strip development. The market's expansion is further supported by innovations and product launches from key players, which enhance testing methods and accessibility. Despite these growth drivers, challenges such as reimbursement issues and the potential inaccuracy of test strips may pose limitations to the market's expansion.

Market Size of Test Strip Industry

Test Strip Market Summary
Study Period 2021 - 2029
Market Size (2024) USD 13.83 Billion
Market Size (2029) USD 16.72 Billion
CAGR (2024 - 2029) 3.87 %
Fastest Growing Market North America
Largest Market Asia-Pacific
Market Concentration Medium

Major Players

Test Strip Market Major Players

*Disclaimer: Major Players sorted in no particular order

Test Strip Market Analysis

The Test Strip Market size is estimated at USD 13.83 billion in 2024, and is expected to reach USD 16.72 billion by 2029, growing at a CAGR of 3.87% during the forecast period (2024-2029).

Factors such as the increasing burden of diabetes and urinary tract infections worldwide, the rising preference for point-of-care (POC) testing, and increasing technological advancements in test strips across the world are predicted to fuel the market's growth.

The test strip market is expected to grow significantly over the projected period, owing to the increased prevalence of diabetes and urinary tract infections (UTIs) worldwide. For instance, according to the data updated by IDF Diabetes Atlas' 10th edition report, diabetes cases are predicted to rise to 643 million by 2030 and 783 million by 2045. Thus, the increasing burden of diabetes among the population worldwide is anticipated to boost the demand for blood glucose test strips, which are widely used to diagnose diabetes, thereby boosting the market.

Moreover, the rising prevalence of diabetes directly translates to a surging demand for blood glucose test strips. These strips are vital tools for individuals with diabetes to monitor their blood sugar levels effectively and manage their condition. For instance, according to a report published by the Diabetologia Journal in February 2024, the declining incidence of type 2 diabetes in Bavaria, Germany, in 2023, driven by effective screening and early diagnosis, necessitates increased monitoring and management, thereby propelling the growth of the test strip market.​

Furthermore, according to the same source, with the prevalence of diabetes expected to rise by 54-77% by 2040 in Germany, the demand for blood glucose monitoring solutions may surge, underscoring the critical role of test strips in managing this chronic condition. These factors are expected to boost the market's growth in the upcoming years.​

Additionally, the increasing rate of unwanted pregnancies is expected to boost the demand for pregnancy test strips. For instance, the data updated by the Guttmacher Institute and the World Health Organization in March 2023 stated that there was a staggering number of unintended pregnancies globally, and more than one in 10 women of all pregnancies were unintended. Such a high number of unexpected pregnancies is expected to bolster the demand for test trips, thereby boosting the market's growth.

Additionally, integrating test strips with mobile apps or telehealth platforms enables real-time data analysis and sharing with healthcare professionals, thereby improving diabetes management. For instance, according to a report published by the Endotext Journal in July 2023, mobile apps connected to blood glucose monitors are driving the growth of the blood glucose test strips landscape by enhancing real-time data collection and analysis, which facilitates timely and precise treatment adjustments. This integration streamlines diabetes management, leading to increased demand for test strips as part of comprehensive glucose monitoring solutions.

Thus, all the aforementioned factors are anticipated to drive the market's growth over the forecast period. However, reimbursement and the inaccuracy of test strips may limit the market during the forecast period.

Test Strip Industry Segmentation

As per the scope of the report, a test strip is a key component of blood glucose testing and urinalysis. It is used to monitor or control a diabetic patient's blood glucose level. It allows people who are pre-diabetic or diabetic to monitor their blood glucose levels regularly without going to a clinic or a diagnostic laboratory.

The test strip market is segmented by product (blood test strips and urine test strips), application (diabetes, pregnancy, urinary tract infection, and other applications), end user (hospitals, home care, and diagnostic laboratories), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers market sizes and forecasts in terms of value (USD) for the above-mentioned segments.

By Product
Blood Test Strips
Urine Test Strips
By Application
Diabetes
Pregnancy
Urinary Tract Infection
Other Applications
By End User
Hospitals
Home Care
Diagnostic Laboratories
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Test Strip Market Size Summary

The test strip market is poised for significant growth, driven by the increasing prevalence of diabetes and urinary tract infections globally. The market's expansion is further supported by the rising preference for point-of-care testing and technological advancements in test strip products. The COVID-19 pandemic initially disrupted the market due to supply chain challenges, but it also spurred innovation, with researchers developing rapid and portable test strips for SARS-CoV-2 detection. This innovation has contributed to the market's resilience and growth trajectory. The demand for blood glucose test strips is expected to rise as diabetes cases continue to increase, while the prevalence of unintended pregnancies is anticipated to boost the demand for pregnancy test strips. Key players in the market are actively engaged in product innovations, which are expected to further propel market growth.

North America is expected to maintain a dominant position in the test strip market, driven by the high incidence of diabetes and urinary tract infections, along with supportive government initiatives and the presence of major market players. The region's market growth is also supported by continuous product launches and advancements in testing technologies. The competitive landscape is characterized by rapid expansion efforts, acquisitions, and partnerships among key players such as Abbott, Acon Lab, and Ascensia. These companies are focusing on increasing market share in developing regions and enhancing the affordability of test strips in low- and middle-income countries. Overall, the test strip market is anticipated to experience robust growth over the forecast period, fueled by these dynamic factors.

Explore More

Test Strip Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Burden of Diabetes and Urinary Tract Infection Across The Globe

      2. 1.2.2 Rising Preference for Point of Care Testing

      3. 1.2.3 Increasing Technological Advancements in Test Strips

    3. 1.3 Market Restraints

      1. 1.3.1 Dearth of Reimbursement Policies

      2. 1.3.2 Lack of Accuracy in Test Results

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD )

    1. 2.1 By Product

      1. 2.1.1 Blood Test Strips

      2. 2.1.2 Urine Test Strips

    2. 2.2 By Application

      1. 2.2.1 Diabetes

      2. 2.2.2 Pregnancy

      3. 2.2.3 Urinary Tract Infection

      4. 2.2.4 Other Applications

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Home Care

      3. 2.3.3 Diagnostic Laboratories

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Test Strip Market Size FAQs

The Test Strip Market size is expected to reach USD 13.83 billion in 2024 and grow at a CAGR of 3.87% to reach USD 16.72 billion by 2029.

In 2024, the Test Strip Market size is expected to reach USD 13.83 billion.

Test Strip Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)